The Good Clinical Trials Collaborative was established in 2020 to coordinate the development and advocate for the implementation of better randomized controlled trials (RCTs) globally. It was led by Professor Sir Martin Landray, co-architect of the COVID-19 RECOVERY trial and was supported by Wellcome and the Gates Foundation.
Guided by the belief that good healthcare is informed by good evidence from good trials, the Collaborative’s has produced guidance to make it easier to do good RCTs, by setting an international benchmark of scientific rigor, ethical integrity, efficiency and quality.
The Guidance was developed through collaboration with a diverse, multidisciplinary group of individuals and organizations with a shared commitment to help accelerate better healthcare across the world. Outlining the five underpinning principles of good RCTs, the guidance is intended to support all parties involved with RCTs of all types of health interventions, in all settings.
Development of the Evaluation Tool and eLearning was led by the following groups:
Good Clinical Trials Collaborative Secretariat
Former members
With special thanks to
Steering Group
Observers
Former members
The work of the Good Clinical Trials Collaborative was supported, and funded, by: